Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
FGF23 and klotho at the intersection of kidney and cardiovascular disease
Cardiovascular disease is the leading cause of death in patients with chronic kidney disease
(CKD). As CKD progresses, CKD-specific risk factors, such as disordered mineral …
(CKD). As CKD progresses, CKD-specific risk factors, such as disordered mineral …
Direct and indirect effects of fibroblast growth factor 23 on the heart
T Nakano, H Kishimoto, M Tokumoto - Frontiers in endocrinology, 2023 - frontiersin.org
Fibroblast growth factor (FGF) 23 is a bone-derived phosphotropic hormone that regulates
phosphate and mineral homeostasis. Recent studies have provided evidence that a high …
phosphate and mineral homeostasis. Recent studies have provided evidence that a high …
Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis
Background In the past decade, fibroblast growth factor 23 (FGF23) has been recognized as
an important biomarker of cardiovascular diseases. This study aimed to assess the …
an important biomarker of cardiovascular diseases. This study aimed to assess the …
[HTML][HTML] Fibroblast growth factor 23 and risk of heart failure subtype: the CRIC (Chronic Renal Insufficiency Cohort) study
Rationale & Objective Heart failure (HF) is an important cause of morbidity and mortality
among individuals with chronic kidney disease (CKD). A large body of evidence from …
among individuals with chronic kidney disease (CKD). A large body of evidence from …
Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome
Aims Abnormalities of mineral metabolism (MM) have been related to cardiovascular
disorders. There are no reports on the prognostic role of MM after an acute coronary …
disorders. There are no reports on the prognostic role of MM after an acute coronary …
Is there a role in acute kidney injury for FGF23 and Klotho?
Cardio-renal syndrome is a clinical condition that has recently been well defined. In acute
kidney disease, this interaction might trigger chronic processes determining the onset of …
kidney disease, this interaction might trigger chronic processes determining the onset of …
[HTML][HTML] New Biomarkers in the Prognostic Assessment of Acute Heart Failure with Reduced Ejection Fraction: Beyond Natriuretic Peptides
Natriuretic peptides are established biomarkers related to the prognosis of heart failure. New
biomarkers have emerged in the field of cardiovascular disease. The prognostic value of …
biomarkers have emerged in the field of cardiovascular disease. The prognostic value of …
HFpEF: New biomarkers and their diagnostic and prognostic value
S parveen Shaik, H hyder Karan, A Singh… - Current Problems in …, 2024 - Elsevier
Heart failure characterized by preserved ejection fraction (HFpEF) poses a substantial
challenge to healthcare systems worldwide and the diagnostic algorithms used currently …
challenge to healthcare systems worldwide and the diagnostic algorithms used currently …
Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidence
Aims Fibroblast growth factor 23 (FGF23) has been implicated in the occurrence of atrial
fibrillation (AF), but its prognostic value in AF patients remains unclear. Methods and results …
fibrillation (AF), but its prognostic value in AF patients remains unclear. Methods and results …
[HTML][HTML] MCP1 Could mediate FGF23 and omega 6/omega 3 correlation inversion in CKD
Fibroblast growth factor 23 (FGF23) concentrations rise after the early stages of chronic
kidney disease (CKD). FGF23 is involved in inflammatory reactions closely associated with …
kidney disease (CKD). FGF23 is involved in inflammatory reactions closely associated with …